Several microRNAs, including miR‐613 (Li et al., 2016b), miR‐138 (Li et al., 2016a), miR‐206 (Zheng et al., 2015), miR‐185 (Fu et al., 2014) and miR‐101 (Hu et al., 2013), have been demonstrated to target c‐MET for cancer proliferation and progression. This evidence concerns the gene MET and cancer.